Melbin



Combined with:

Indications and Reactions:

Role Indications Reactions
Secondary
Diabetes Mellitus 33.6%
Hypertension 14.5%
Lumbar Spinal Stenosis 7.3%
Type 2 Diabetes Mellitus 6.4%
Nerve Injury 5.9%
Parkinson's Disease 5.5%
Constipation 5.0%
Cardiovascular Disorder 4.5%
Rheumatoid Arthritis 2.7%
Hyperlipidaemia 2.3%
Cataract 1.8%
Blood Glucose Increased 1.4%
Cerebrovascular Accident 1.4%
Hypercholesterolaemia 1.4%
Nausea 1.4%
Nightmare 1.4%
Blood Glucose Decreased 0.9%
Bronchiectasis 0.9%
Cardiac Failure 0.9%
Cellulitis 0.9%
Hypoglycaemia 20.0%
Rash Generalised 11.1%
Respiratory Failure 8.9%
Loss Of Consciousness 6.7%
Altered State Of Consciousness 4.4%
Duodenal Ulcer Haemorrhage 4.4%
Hypoglycaemic Coma 4.4%
Hypoglycaemic Unconsciousness 4.4%
Liver Disorder 4.4%
Photophobia 4.4%
Platelet Count Decreased 4.4%
Rectal Cancer 4.4%
Aspartate Aminotransferase Increased 2.2%
Autoimmune Hepatitis 2.2%
Blood Alkaline Phosphatase Increased 2.2%
Cardio-respiratory Arrest 2.2%
Decreased Appetite 2.2%
Dehydration 2.2%
Heart Disease Congenital 2.2%
Hepatic Function Abnormal 2.2%
Concomitant
Diabetes Mellitus 32.7%
Hypertension 16.9%
Type 2 Diabetes Mellitus 10.1%
Drug Use For Unknown Indication 7.5%
Rheumatoid Arthritis 4.0%
Prophylaxis 3.6%
Hyperlipidaemia 3.4%
Insomnia 2.4%
Acquired Immunodeficiency Syndrome 2.2%
Constipation 2.2%
Product Used For Unknown Indication 2.0%
Herpes Zoster 1.8%
Cancer Pain 1.7%
Psoriasis 1.5%
Cardiac Failure 1.4%
Gastric Ulcer 1.3%
Gastritis 1.3%
Cerebral Infarction 1.3%
Chest Pain 1.3%
Colorectal Cancer 1.3%
Hepatic Function Abnormal 14.6%
Rash 7.9%
Hypoglycaemia 7.3%
Vomiting 7.3%
Pyrexia 5.6%
Rhabdomyolysis 5.6%
White Blood Cell Count Decreased 5.6%
Blood Creatine Phosphokinase Increased 4.5%
Interstitial Lung Disease 4.5%
Cerebral Infarction 3.9%
Glycosylated Haemoglobin Increased 3.9%
Myocardial Infarction 3.9%
Diabetes Mellitus 3.4%
Liver Disorder 3.4%
Renal Failure Acute 3.4%
Sinus Bradycardia 3.4%
Umbilical Cord Around Neck 3.4%
Chronic Myeloid Leukaemia 2.8%
Rectal Cancer 2.8%
Renal Impairment 2.8%
Interacting
Diabetes Mellitus 57.1%
Hypertension 28.6%
Hyperlipidaemia 14.3%
Rhabdomyolysis 100.0%